Atacicept
Atacicept (TACI-Ig) is a is a recombinant fusion protein containing the extracellular, ligand-binding portion of the TACI receptor and the Fc portion of human IgG. Atacicept inhibits B cell stimulation by binding to B lymphocyte stimulator and a proliferation-inducing ligand. Atacicept can be used in research of B-cell autoimmune disease[1][2].
Product Specifications
CAS Number
[845264-92-8]
Product Name Alternative
TACI-Ig; TACI-Fc 5
UNSPSC
12352203
Target
TNF Receptor
Type
Inhibitory Antibodies
Related Pathways
Apoptosis
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/atacicept.html
Purity
99.5
Solubility
10 mM in DMSO
Smiles
[Atacicept]
Molecular Weight
(70.45 kDa)
References & Citations
[1]Gross JA, et, al. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS. Immunity. 2001 Aug;15 (2) :289-302. |[2]Gross JA, et, al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature. 2000 Apr 27;404 (6781) :995-9.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
NBP3-28203-100ug 100 µg
CHO Monoclonal FCRL5/FcRH5/IRTA2 Antibody (DFRF4539A) - Humanized - (Dry Ice)
Ask
View Details 
MPX2045K Each
Magic™ Membrane Protein Human SUN2 (Sad1 and UNC84 domain containing 2) Expressed in vitro E.coli expression system, Full Length
Ask
View Details